|
**Overview**: Tropical Fever Panel**Introduction**: The Tropical Fever Panel is a diagnostic tool designed for tropical infection screening using serum samples. In India, undifferentiated tropical fevers (dengue, malaria, typhoid, scrub typhus, leptospirosis) cause millions of cases annually (dengue ~100,000-200,000/year, malaria ~400,000, typhoid ~1 million), with high seasonal peaks in monsoon and rural/low-SES areas. High morbidity from under-testing leading to delayed specific therapy, progression to shock/organ failure, or misdiagnosis. Per infectious disease practices aligned with ICMR, National Vector Borne Disease Control Programme, and National Centre for Disease Control guidelines, the test employs immunoassay/microscopy for Dengue NS1 Ag, Malaria Antigen, and Typhoid IgM over 1â€"2 days with high accuracy, valuable for rapid syndromic diagnosis in febrile illness. This diagnostic falls under infectious disease screening and targets patients with acute fever, headache, myalgia, or rash in endemic areas, addressing accurate detection to guide antimalarials, supportive care, or antibiotics. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling quick tropical fever profiling and reducing mortality in high-burden regions. Its serum-based approach ensures reliable antigen/antibody detection.**Other Names**: Trop Fever Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry/immunology, compliant with 2025 standards.**Historical Milestone**: Dengue NS1 + malaria + typhoid panel standard in fever clinics; in India, integrated in IDSP surveillance.**Purpose**: The test assesses 3 parameters including Dengue NS1 Ag to guide tropical infection screening, detect common pathogens, inform targeted therapy.**Test Parameters**: 1. Dengue NS1 Ag, 2. Malaria Antigen, 3. Typhoid IgM.**Pretest Condition**: No fasting required; patients should have acute fever.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve antigen/antibody integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on fever duration, travel, mosquito exposure.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected tropical fever including shock, benefits of screening, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay/microscopy by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1â€"2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Positive Dengue NS1/Malaria antigen/Typhoid IgM confirms specific etiology, necessitating specialist input.**Specialist Consultation**: Infectious disease specialists should be consulted for management.**Additional Supporting Tests**: Dengue IgM/IgG, blood culture, NS1 PCR for confirmation.**Test Limitations**: Early/late window periods; comprehensive approach required.**References**: Indian Journal of Medical Microbiology 2024, Tropical Fever Studies India 2023. |
